Ferritin Mitochondrial (FTMT)

<table class="infobox infobox-protein">
<tr><th class="infobox-header" colspan="2">Ferritin Mitochondrial (FTMT)</th></tr>
<tr><td class="label">Gene</td><td>[FTMT](/genes/ftmt)</td></tr>
<tr><td class="label">UniProt</td><td><a href="https://www.uniprot.org/uniprot/P04183" target="_blank">P04183</a></td></tr>
<tr><td class="label">PDB</td><td><a href="https://www.rcsb.org/structure/5ML2" target="_blank">5ML2</a></td></tr>
<tr><td class="label">Molecular Weight</td><td>~25 kDa (subunit), 200 kDa (24-mer)</td></tr>
<tr><td class="label">Subcellular Localization</td><td>Mitochondria (mitochondrial matrix)</td></tr>
<tr><td class="label">Protein Family</td><td>Ferritin family</td></tr>
<tr><td class="label">Aliases</td><td>MtF, Mitochondrial Ferritin</td></tr>
</table>

Ferritin Mitochondrial (FTMT)

Introduction

Mitochondrial Ferritin (FTMT) is a specialized iron-storage protein encoded by the [FTMT](/genes/ftmt) gene. Unlike cytosolic ferritin, FTMT is targeted to mitochondria and plays crucial roles in iron homeostasis, oxidative stress protection, and cellular survival. FTMT has attracted significant attention in neurodegenerative disease research due to the well-established role of iron dysregulation and oxidative stress in [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease) [1].

Structure

FTMT has a unique structure adapted for mitochondrial function:

Monomer Structure

• ~25 kDa per subunit
• Contains the classic ferritin fold
• Iron-binding sites in the ferroxidase center

...

<table class="infobox infobox-protein">
<tr><th class="infobox-header" colspan="2">Ferritin Mitochondrial (FTMT)</th></tr>
<tr><td class="label">Gene</td><td>[FTMT](/genes/ftmt)</td></tr>
<tr><td class="label">UniProt</td><td><a href="https://www.uniprot.org/uniprot/P04183" target="_blank">P04183</a></td></tr>
<tr><td class="label">PDB</td><td><a href="https://www.rcsb.org/structure/5ML2" target="_blank">5ML2</a></td></tr>
<tr><td class="label">Molecular Weight</td><td>~25 kDa (subunit), 200 kDa (24-mer)</td></tr>
<tr><td class="label">Subcellular Localization</td><td>Mitochondria (mitochondrial matrix)</td></tr>
<tr><td class="label">Protein Family</td><td>Ferritin family</td></tr>
<tr><td class="label">Aliases</td><td>MtF, Mitochondrial Ferritin</td></tr>
</table>

Ferritin Mitochondrial (FTMT)

Introduction

Mitochondrial Ferritin (FTMT) is a specialized iron-storage protein encoded by the [FTMT](/genes/ftmt) gene. Unlike cytosolic ferritin, FTMT is targeted to mitochondria and plays crucial roles in iron homeostasis, oxidative stress protection, and cellular survival. FTMT has attracted significant attention in neurodegenerative disease research due to the well-established role of iron dysregulation and oxidative stress in [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease) [1].

Structure

FTMT has a unique structure adapted for mitochondrial function:

Monomer Structure

• ~25 kDa per subunit
• Contains the classic ferritin fold
• Iron-binding sites in the ferroxidase center

Quaternary Structure

• Forms 24-mer spherical shells (similar to other ferritins)
• Hollow cage-like structure
• Can store up to ~2000 iron atoms per molecule

Mitochondrial Targeting

• N-terminal mitochondrial targeting sequence
• Processed upon mitochondrial import
• Matrix-facing protein

Normal Function

Iron Storage and Homeostasis

FTMT's primary function is iron management:

• Iron sequestration: Stores excess iron in safe form
• Ferroxidase activity: Converts toxic Fe2+ to Fe3+
• Iron availability: Regulates iron for mitochondrial enzymes
• Cellular iron balance: Maintains iron homeostasis

Oxidative Stress Protection

By managing iron, FTMT protects against oxidative stress:

• Prevents Fenton chemistry: Reduces hydroxyl radical formation
• Lipid peroxidation prevention: Protects membranes from [ROS](/entities/reactive-oxygen-species)
• DNA protection: Reduces oxidative DNA damage

Mitochondrial Function

FTMT supports mitochondrial health:

• Iron-sulfur cluster synthesis: Provides iron for Fe-S cluster assembly
• Heme synthesis: Supplies iron for heme biosynthesis
• Respiratory chain function: Protects mitochondria from iron-induced damage

Neuronal Protection

In the nervous system:

• Neuroprotection: Guards [neurons](/entities/neurons) from iron-mediated toxicity
• Synaptic function: Supports synaptic iron homeostasis
• Myelination: Important for oligodendrocyte function

Role in Neurodegeneration

Alzheimer's Disease

FTMT is critically involved in AD pathogenesis:

Iron dysregulation:

• Iron accumulates in AD brains [2]
• FTMT expression is altered in AD neurons
• May contribute to iron-induced [Aβ](/proteins/amyloid-beta) toxicity

Oxidative stress:

• Enhanced oxidative stress in AD
• FTMT provides antioxidant protection
• [Ferroptosis](/entities/ferroptosis) may contribute to neuronal loss

Mitochondrial dysfunction:

• Mitochondrial iron overload in AD
• FTMT protects mitochondria from iron damage

Parkinson's Disease

FTMT is highly relevant to PD:

Iron accumulation:

• Iron accumulates in substantia nigra in PD [3]
• FTMT may be protective against iron-induced dopaminergic neuron loss
• Genetic variants of FTMT may modify PD risk

Mitochondrial dysfunction:

• Central to PD pathogenesis
• FTMT protects dopaminergic neurons
• Iron-induced mitochondrial damage is a key mechanism

Neuroprotection:

• Overexpression of FTMT protects dopaminergic neurons
• Potential therapeutic target

Other Neurodegenerative Conditions

• Amyotrophic lateral sclerosis: Iron dysregulation in motor neurons
• Huntington's disease: Iron accumulation in striatum
• Ferroptosis: New iron-dependent cell death pathway

Therapeutic Implications

FTMT is a promising therapeutic target:

Iron Modulation

• Iron chelators (deferoxamine, deferasirox)
• Small molecules that modulate FTMT expression

Gene Therapy

• AAV-mediated FTMT delivery
• CRISPR approaches

Small Molecule Activators

• FTMT expression enhancers
• Ferroptosis inhibitors

Research Findings

Key findings:

• FTMT expression is tissue-specific
• Genetic variants affect neurodegenerative disease risk
• FTMT-based therapies are in development

See Also

• [FTMT Gene](/genes/ftmt)
• [Ferritin Light Chain](/proteins/ftl-protein)
• [Ferritin Heavy Chain](/proteins/fth1-protein)
• [Iron Metabolism](/mechanisms/iron-metabolism)
• [Oxidative Stress](/mechanisms/oxidative-stress)
• [Alzheimer's Disease Pathogenesis](/mechanisms/alzheimers-disease-pathogenesis)
• [Parkinson's Disease Pathogenesis](/mechanisms/parkinsons-disease-pathogenesis)
• [Ferroptosis](/mechanisms/ferroptosis)

References

[Unknown, Cozzolino & Ferri, Mitochondrial ferritin in neurodegeneration (2019) (2019)](https://doi.org/10.1007/s12035-019-01756-w)

[Rashid et al., Iron in Alzheimer disease (2019) (2019)](https://doi.org/10.1002/jnr.24521)

[Oakley et al., Iron in Parkinson disease (2020) (2020)](https://doi.org/10.1002/mds.28005)

[Zhang et al., Ferroptosis in neurodegeneration (2018) (2018)](https://doi.org/10.1038/s41580-018-0043-9)